Matches in SemOpenAlex for { <https://semopenalex.org/work/W2976572331> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2976572331 abstract "Objective: To assess the safety and efficacy of incobotulinumtoxinA for benign essential blepharospasm (BEB) in toxin-naive subjects. Background: IncobotulinumtoxinA is efficacious for BEB. This was the first, randomized, Phase III study (NCT01896895) in toxin-naive subjects. Here we present data from the complete study. Design/Methods: Subjects (18–80 years) with bilateral BEB, Jankovic Rating Scale (JRS) severity subscore ≥2, and no BEB treatment with any botulinum neurotoxin (BoNT) serotype within past ≥12 months, were enrolled. In the main period (MP), subjects were randomized (1:1:1) in a double-blind manner to single intramuscular injections of incobotulinumtoxinA 25U (12.5U/eye), 50U (25U/eye) or placebo, with an observation period (OP) of 6–20 weeks. Subjects with a need for re-injection (JRS severity subscore ≥2 at final MP visit) were eligible for the open-label extension period (EP): a single dose of incobotulinumtoxinA ≤70U (≤35U/eye) with a 6–20-week OP. Mean change from baseline in JRS severity subscore and safety were assessed. Results: Overall, 61 subjects were randomized (mean 55.0 years; 59.0% female); 55 completed the MP and 39 entered and completed the EP. At MP Week 6, JRS severity subscore significantly improved from baseline with incobotulinumtoxinA 50U versus placebo (p=0.0004), and numerically improved with incobotulinumtoxinA 25U versus placebo. Sustained improvements were seen with incobotulinumtoxinA ≤70U from EP baseline to EP Week 6 (−1.2) and to EP final visit (−0.7), and from MP baseline to EP final visit (−1.0) (all p Conclusions: IncobotulinumtoxinA showed sustained efficacy in toxin-naive subjects with BEB. Long-term safety results were in line with the known safety profile. Disclosure: Dr. Mitsikostas has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan, Biogen, Electrocore, Cefaly, Eli Lilly, Merck-Serono, Novartis, Roche, Sanofi, Teva. Dr. Mitsikostas has received personal compensation in an editorial capacity for Journal of Headache and Pain. Dr. Mitsikostas has received research support from Biogen, Eli Lilly, Sanofi. Dr. Dekundy has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merz Pharmaceuticals GmbH. Dr. Sternberg has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities as an employee at Merz Pharmaceuticals and AbbVie Deutschland GmbH & Co. KG. Dr. Althaus has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Employee of Merz Pharmaceuticals. Dr. Althaus holds stock and/or stock options in Fresenius SE, Co KGaA. Dr. Pagan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merz, US WorldMeds, Acadia, Teva, AbbVie, Sunovion, and Acorda. Dr. Pagan has received research support from US WorldMeds and Medtronic." @default.
- W2976572331 created "2019-10-03" @default.
- W2976572331 creator A5046518155 @default.
- W2976572331 creator A5047519313 @default.
- W2976572331 creator A5067591694 @default.
- W2976572331 creator A5088691653 @default.
- W2976572331 creator A5088802584 @default.
- W2976572331 date "2019-04-09" @default.
- W2976572331 modified "2023-09-23" @default.
- W2976572331 title "Long-term Safety and Efficacy of IncobotulinumtoxinA for the Treatment of Blepharospasm in Botulinum Toxin-naïve Subjects: Results of a Phase III Study (S28.005)" @default.
- W2976572331 hasPublicationYear "2019" @default.
- W2976572331 type Work @default.
- W2976572331 sameAs 2976572331 @default.
- W2976572331 citedByCount "0" @default.
- W2976572331 crossrefType "journal-article" @default.
- W2976572331 hasAuthorship W2976572331A5046518155 @default.
- W2976572331 hasAuthorship W2976572331A5047519313 @default.
- W2976572331 hasAuthorship W2976572331A5067591694 @default.
- W2976572331 hasAuthorship W2976572331A5088691653 @default.
- W2976572331 hasAuthorship W2976572331A5088802584 @default.
- W2976572331 hasConcept C126322002 @default.
- W2976572331 hasConcept C142724271 @default.
- W2976572331 hasConcept C168563851 @default.
- W2976572331 hasConcept C1862650 @default.
- W2976572331 hasConcept C204787440 @default.
- W2976572331 hasConcept C27081682 @default.
- W2976572331 hasConcept C2777478456 @default.
- W2976572331 hasConcept C2778817116 @default.
- W2976572331 hasConcept C42219234 @default.
- W2976572331 hasConcept C71924100 @default.
- W2976572331 hasConceptScore W2976572331C126322002 @default.
- W2976572331 hasConceptScore W2976572331C142724271 @default.
- W2976572331 hasConceptScore W2976572331C168563851 @default.
- W2976572331 hasConceptScore W2976572331C1862650 @default.
- W2976572331 hasConceptScore W2976572331C204787440 @default.
- W2976572331 hasConceptScore W2976572331C27081682 @default.
- W2976572331 hasConceptScore W2976572331C2777478456 @default.
- W2976572331 hasConceptScore W2976572331C2778817116 @default.
- W2976572331 hasConceptScore W2976572331C42219234 @default.
- W2976572331 hasConceptScore W2976572331C71924100 @default.
- W2976572331 hasOpenAccess W2976572331 @default.
- W2976572331 hasRelatedWork W1042487492 @default.
- W2976572331 hasRelatedWork W2562731026 @default.
- W2976572331 hasRelatedWork W2794555652 @default.
- W2976572331 hasRelatedWork W2795807623 @default.
- W2976572331 hasRelatedWork W2803952614 @default.
- W2976572331 hasRelatedWork W2806417025 @default.
- W2976572331 hasRelatedWork W2806435685 @default.
- W2976572331 hasRelatedWork W2806687972 @default.
- W2976572331 hasRelatedWork W2808055426 @default.
- W2976572331 hasRelatedWork W2808114370 @default.
- W2976572331 hasRelatedWork W2809523820 @default.
- W2976572331 hasRelatedWork W2809684180 @default.
- W2976572331 hasRelatedWork W2885430857 @default.
- W2976572331 hasRelatedWork W2888596619 @default.
- W2976572331 hasRelatedWork W2898365980 @default.
- W2976572331 hasRelatedWork W3015657679 @default.
- W2976572331 hasRelatedWork W3100352795 @default.
- W2976572331 hasRelatedWork W3126954968 @default.
- W2976572331 hasRelatedWork W3159959646 @default.
- W2976572331 hasRelatedWork W2809596465 @default.
- W2976572331 hasVolume "92" @default.
- W2976572331 isParatext "false" @default.
- W2976572331 isRetracted "false" @default.
- W2976572331 magId "2976572331" @default.
- W2976572331 workType "article" @default.